1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Andes Biotechnologies: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor Andes-1537 for Injection - Tumor, Solid, Gall Bladder Cancer | Phase 1 | Completed | Andes Biotechnologies | 67 | 2019-04-26 | 2022-02-24 |
| Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors Andes-1537 for Injection - Advanced Unresectable Solid Tumors | Phase 1 | Terminated | Andes Biotechnologies | 22 | 2015-12-08 | 2018-10-18 |
Neoplasms (2) · Carcinoma (1) · Colorectal Neoplasms (1) · Gallbladder Neoplasms (1) · Pancreatic Neoplasms (1) · Stomach Neoplasms (1) · Uterine Cervical Neoplasms (1)
Injections (2)
Chile (1) · United States (1)
Bernadita Mendez, PhD (1) · Pamela Munster, MD (1)